Prematurity Prevalence Among T1D Patients and Its Characteristics Compared With Premature-born Non-diabetic Patients

NCT02929953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3600

Last updated 2019-08-13

No results posted yet for this study

Summary

The aims of this study are:

1. To assess the prevalence of prematurity, especially early prematurity, among T1D patients, and compare it to the prematurity prevalence among the non-diabetic general population in Israel.
2. To characterize epidemiological and clinical factors that differ between premature-born patients that developed T1D and those that have not, including the nutritional and therapeutic properties in NICU.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

OTHER

chart review

data from charts and from registries will be compared

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    collaborator OTHER
  • Wolfson Medical Center

    collaborator OTHER_GOV
  • Ziv Medical Center

    collaborator OTHER
  • Schneider Children's Medical Center, Israel

    collaborator OTHER
  • Tel-Aviv Sourasky Medical Center

    collaborator OTHER_GOV
  • Maccabi Healthcare Services, Israel

    collaborator OTHER
  • Kaplan Medical Center

    collaborator OTHER
  • HaEmek Medical Center, Israel

    collaborator OTHER
  • Soroka University Medical Center

    collaborator OTHER
  • Rambam Health Care Campus

    collaborator OTHER
  • Hadassah Medical Organization

    collaborator OTHER
  • Assaf Harofeh MC

    lead OTHER_GOV

Principal Investigators

  • marianna Rachmiel, md · Assaf Haroffeh Medical Center

Eligibility

Min Age
1 Year
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02929953 on ClinicalTrials.gov